Deuruxolitinib
sun pharma
['rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)', 'deuruxolitinib', 'ruxolitinib']
late-breaking phase 3 data at aad 2023 show oral investigational medicine deuruxolitinib significantly improved ... - yahoo finance 